ecancermedicalscience

Review

Cell-cell fusion as a potential target in cancer therapy

6 Aug 2009
JM Gasent-Blesa, VA Candel

In the fight against cancer, new and more specific targets are needed. Here, we offer an example of a potential target that has not been widely studied, namely the syncytin protein. Syncytin is expressed mainly in the human placenta and is implicated in placental syncytiotrophoblast cell fusion. Not much is known about the role of syncytin in cancer, but the existing data call for more intense research. Its retroviral origin and particular tissue distribution make syncytin an interesting potential target in cancer therapy.

Related Articles

Julia Palma, Sofía Aljaro, Daniela Arce, Milena Villarroel, Federico Antillón, Luiz Lopes, Nataly Mercado, Adriana Morais, Andrés Portilla, Leonardo Arana, Guillermo Chantada, Mónica Cypriano, Soad Fuentes, Augusto Pereira, Lourdes Vega, Nubia Zuñiga, Liliana Vásquez, Andrea Capellano, Paola Friedrich
Anjali Rathee, Priyanshi Dixit, Surya Kant Tiwari, Mukul Aggarwal, Pradeep Kumar, Rishi Dhawan, Richa Chauhan, Jasmita Dass, Ganesh Kumar Vishwanathan, Tulika Seth, Manoranjan Mahapatra
Ruqayya Manzoor, Hijab Shaheen, Ana Farooq, Nazia Rafique, Nuzhat Yasmeen, Junaid Jamshed
José Darío Portillo-Miño, John Jairo Calderon, David Bettin Gonzalez, Yeison Carlosama, Lorena Lagarde, Rafael Parra-Medina
Joshua Agilinko, Sonam Patel, Jogitha Selvarajah, Nicholas Tekkis, Mathew Vithayathil, Suzette Samlalsingh